December 29, 2021
With the Omicron variant of COVID-19 surging through the country, access to timely testing is becoming a major constraint to heading off the surge. The White House announced new measures to make at-home tests more readily available beginning in January. Unfortunately, a lot of questions remain as to how health insurers will pay for the over-the-counter tests. USA Today recently spoke with Rena Conti, Associate Professor of Markets, Public Policy, & Law to discuss the issues surrounding barriers to access.
“If consumers face out-of-pocket costs, even if they’re relatively cheap, the likelihood is that they won’t use the tests.”Rena Conti
Associate Professor of MARKETS, PUBLIC POLICY, & LAW
- The Great Resignation: Historical Data and a Deeper Analysis Show It’s Not as Great as Screaming Headlines Suggest
- The Wisdom of the Crowd and Prediction Markets
- Nature Human Behavior: Understanding, Explaining, and Utilizing Medical Artificial Intelligence
- Boston Globe: The Next Generation of Business Leaders is Entering a Changed World of Work. Will Their Education Prepare Them?
- ZDNet: Amazing Things Happen When IT and Business Leaders Collaborate
- USA Today: How Easy Will Health Insurers Make it to Get Free, At-Home COVID-19 Tests?
- Harvard Business Review: Digital Transformation Changes How Companies Create Value
- Expert Take: Regulating Prescription Drug Prices While Increasing Innovation
- Forbes: OSHA Launches Investigation Into Amazon Warehouse Hit By Tornado
- StrategicCFO360: First Read: Your Digitalization Agenda